Fortem Financial Group, LLC Novo Nordisk A S Transaction History

Fortem Financial Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$47.54 - $53.43 $228,382 - $256,677	-4,804 Closed	0 $0
Q2 2019 Aug 09, 2019	SELL	$46.79 - $52.47 $17,405 - $19,518	-372 Reduced 7.19%	4,804 $245,000
Q1 2019 May 13, 2019	SELL	$46.36 - $52.63 $1,808 - $2,052	-39 Reduced 0.75%	5,176 $271,000
Q4 2018 Feb 14, 2019	BUY	$41.54 - $47.25 $216,631 - $246,408	5,215 New	5,215 $240,000

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $192B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Fortem Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Fortem Financial Group, LLC with notifications on news.